Manne et al. found that in whole blood from COVID-19 patients, platelet activation by 2MeSADP, TRAP, and collagen-related peptides (CRPs) resulted in decreased PAC-1 binding, irrespective of disease status, compared to healthy donors. The gene discussed is CD40LG; the disease is COVID-19.